Progression of alcoholic and non-alcoholic steatohepatitis: Common metabolic aspects of innate immune system and oxidative stress

Drug Metabolism and Pharmacokinetics

Volumn 26, Issue 1, 2011, Pages 30-46

  Sakaguchi, Shuhei ^a   Takahashi, Shougo ^a   Sasaki, Takamitsu ^a   Kumagai, Takeshi ^a   Nagata, Kiyoshi ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Alcoholic liver disease (ALD); CYP2E1; Gut derived endotoxin; Innate immune system; Non alcoholic fatty liver disease (NAFLD); Non alcoholic steatohepatitis (nash); Oxidative stress

Indexed keywords

BACTERIAL TOXIN; CYTOCHROME P450 2E1; CYTOKINE; ENDOTOXIN; REACTIVE OXYGEN METABOLITE;

ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; CYTOKINE RELEASE; DISEASE COURSE; FATTY LIVER; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INNATE IMMUNITY; LIPID PEROXIDATION; LIVER CELL DAMAGE; METABOLISM; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79952760290     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-10-RV-087     Document Type: Review

References (82)

1. McClain, C. J., Song, Z., Barve, S. S., Hill, D. B. and Deaciuc, I.: Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol., 287: G497-G502 (2004).
2. Bode, C. and Bode, J. C.: Activation of the innate immune system and alcoholic live disease: Effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol. Clin. Exp. Res., 29: 166S-171S (2005).
3. Mandrekar, P.: Signaling mechanisms in alcoholic liver injury: Role of transcription factor, kinase and heat shock proteins. World J. Gastroenterol., 13: 4979-4985 (2007).
4. Vidali, M., Hietala, J., Occhino, G., Ivaldi, A., Sutti, S., Niemelä, O. and Albano, E.: Immune responses against oxidative stressderived antigens are associated with increased circulating tumor necrosis factor-α in heavy drinkers. Free Radic. Biol. Med., 45: 306-311 (2008).
5. Mandrekar, P. and Szabo, G.: Signalling pathways in alcoholinduced liver inflammation. J. Hepatol., 50: 1258-1266 (2009).
6. Schaffert, C. S., Duryee, M. J., Hunter, C. D., Hamilton, B. C., 3rd, DeVeney, A. L., Huerter, M. M., Klassen, L. W. and Thiele, G. M.: Alcohol metabolites and lipopolysaccharide: Roles in the development and/or progression of alcoholic liver disease. World J. Gastroenterol., 15: 1209-1218 (2009).
7. Wheeler, M. D.: Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res. Health, 27: 300-306 (2003).
8. Nanji, A. A.: Role of Kupffer cells in alcoholic hepatitis. Alcohol, 27: 13-15 (2002).
9. McClain, C. J., Hill, D. B., Song, Z., Deacius, I. and Shirish, B.: Monocyte activation in alcoholic liver disease. Alcohol, 27: 53-61 (2002).
10. Tilg, H. and Diehl, A. M.: Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med., 343: 1467-1476 (2000).
11. Akira, S., Takeda, K. and Kaisho, T.: Tool-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol., 2: 675-680 (2001).
12. Angulo, P.: Nonalcoholic fatty liver disease. N. Engl. J. Med., 346: 1221-1231 (2002).
13. Malaguarnera, M., Di Rosa, M., Nicoletti, F. and Malaguarnera, L.: Molecular mechanisms involved in NAFLD progression. J. Mol. Med., 87: 679-695 (2009).
14. Portincasa, P., Grattagliano, I., Palmieri, V. O. and Palasciano, G.: Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin. Biochem., 38: 203-217 (2005).
15. Ong, J. P. and Younossi, Z. M.: Epidemiology and natural history of NAFLD and NASH. Clin. Liver Dis., 11: 1-16 (2007).
16. Starley, B. Q., Calcagno, C. J. and Harrison, S. A.: Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology, 51: 1820-1832 (2010).
17. Lieber, C. S.: Cytochrome P-4502E1: its physiological and pathological role. Physiol. Rev., 77: 517-544 (1997).
18. Wu, D. and Cederbaum, A. I.: Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. Toxicol. Appl. Pharmacol., 207: 70-76 (2005).
19. Lieber, C. S.: Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol, 34: 9-19 (2004).
20. Nagata, K., Suzuki, H. and Sakaguchi, S.: Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J. Toxicol. Sci., 32: 453-468 (2007).
21. Diehl, A. M.: Lessons from animal models of NASH. Hepatol. Res., 33: 138-144 (2005).
22. Corterz-Pinto, H., deMoura, M. C. and Day, C. P.: Non-alcoholic steatohepatitis: from cell biology to clinical practice. J. Hepatol., 44: 197-208 (2006).
23. Kamada, Y., Takehara, T. and Hayashi, N.: Adipocytokines and liver disease. J. Gastroenterol., 43: 811-822 (2008).
24. Dowman, J. K., Tomlinson, J. W. and Newsome, P. N.: Pathogenesis of non-alcoholic fatty liver disease. Q. J. Med., 103: 71-83 (2010).
25. Szabo, G. and Bala, S.: Alcoholic liver disease and the gut-liver axis. World J. Gastroenterol., 16: 1321-1329 (2010).
26. Rush, B. F., Sori, A. J., Thomas, F. M., Smith, S., Flanagan, J. J. and Machiedo, G. W.: Endotoxemia and bacteremia during hemorrhagic shock. Ann. Surg., 207: 549-554 (1988).
27. Deith, E. A., Ma, W. J., Ma, L., Berg, R. and Specian, R. D.: Endotoxin-induced bacterial translocation: a study of mechanisms. Surgery, 106: 292-300 (1989).
28. Mori, T., Yamamoto, H., Tabata, T., Shimizu, T., Endo, Y., Hanasawa, K., Fujimiya, M. and Tani, T.: A free radical scavenger, edaravone (MCI-186), diminishes intestinal neutrophil lipid peroxidation and bacterial translocation in a rat hemorrhagic shock model. Crit. Care Med., 33: 1064-1069 (2005).
29. Messingham, K. A., Faunce, D. E. and Kovacs, E. J.: Alcohol, injury, and cellular immunity. Alcohol, 28: 137-149 (2002).
30. Mathurin, P., Deng, Q. G., Keshavarzian, A., Choudhary, S., Holmes, E. W. and Tsukamoto, H.: Exacerbation of alcoholic liver by enteral endotoxin in rat. Hepatology, 32: 1008-1017 (2000).
31. Tamai, H., Kato, S., Horie, Y., Ohki, E., Yokoyama, H. and Ishii, H.: Effect of acute ethanol administration on the intestinal absorption of endotoxin in rat. Alcohol. Clin. Exp. Res., 24: 390-394 (2000).
32. Jarvelainen, H. A., Fang, C., Ingelmann-Sundberg, M. and Lindros, K. O.: Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and pro-inflammatory and anti-inflammatory cytokines. Hepatology, 29: 1503-1510 (1999).
33. Morita, T., Naito, H., Ito, Y. and Nakajima, T.: Hypothesis of seven balances: molecular mechanisms behind alcoholic liver diseases and association with PPARα. J. Occup. Health, 51: 391-403 (2009).
34. Nanji, A. A., Khettry, U., Sadrzadeh, S. M. and Yamanaka, T.: Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am. J. Pathol., 142: 367-373 (1993).
35. Thurman, R. G.: Mechanisms of hepatic toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am. J. Physiol., 275: G605-G611 (1998).
36. Yin, M., Wheeler, M. D., Kono, H., Bradford, B. U., Gallucci, R. M., Luster, M. I. and Thurman, R. G.: Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology, 117: 942-952 (1999).
37. Vidali, M., Stewart, S. F. and Albano, E.: Interplay between oxidative stress and immunity in the progression of alcoholmediated liver injury. Trends Mol. Med., 14: 63-71 (2008).
38. Takeda, K. and Akira, S.: TLR signaling pathways. Semin. Immunol., 16: 3-9 (2004).
39. Szabo, G., Dolganiuc, A. and Mandrekar, P.: Pattern recognition receptors: a contemporary view on liver diseases. Hepatology, 44: 287-298 (2006).
40. Gutsmann, T., Müller, M., Carroll, S. F., MacKenzie, R. C., Wiese, A. and Seydel, U.: Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPSinduced activation of mononuclear cells. Infect. Immun., 69: 6942-6950 (2001).
41. Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., Wheeler, M. D., Gabele, E., Isayama, F. and Thurman, R. G.: Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J. Immunol., 168: 2963-2969 (2002).
42. Yin, M., Bradford, B. U., Wheeler, M. D., Uesugi, T., Froh, M., Goyert, S. M. and Thurman, R. G.: Reduced early alcohol-induced liver injury in CD14-deficient mice. J. Immunol., 166: 4737-4742 (2001).
43. Su, G. L., Klein, R. D., Aminlari, A., Zhang, H. Y., Steinstraeeser, L., Alarcon, W. H., Remick, D. G. and Wang, S. C.: Kupffer cell activation by lipopolysaccharide in rat: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology, 31: 932-936 (2000).
44. Kono, H., Wheeler, M. D., Rusyn, I., Lin, M., Seabra, V., Rivera, C. A., Bradford, B. U., Forman, D. T. and Thurman, R. G.: Gender differences in early alcohol-induce liver injury: role of CD14, NF-ÏB, and TNF-α. Am. J. Physiol. Gastrointest. Liver Physiol., 278: G652-G661 (2000).
45. Lukkari, T. A., Järveläinen, H. A., Oinonen, T., Kettunen, E. and Lindros, K. O.: Short-term ethanol exposure increases the expression of Kupffer cell CD14 receptor and lipopolysaccharide binding protein in rat liver. Alcohol Alcohol., 34: 311-319 (1999).
46. Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U. and Thurman, R. G.: Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology, 34: 101-108 (2001).
47. Tilg, H. and Diehl, A. M.: Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med., 343: 1467-1476 (2000).
48. Yin, M., Gabele, E., Wheeler, M. D., Connor, H., Bradford, B. U., Dikalona, A., Rusyn, I., Mason, R. and Thurman, R. G.: Alcohol-induced free radicals in mice. Direct toxicants or signaling molecules? Hepatology, 34: 935-942 (2001).
49. Malhi, H., Gores, G. J. and Lemasters, J. J.: Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology, 43: S31-S44 (2006).
50. Hsueh, W., Sun, X., Rjoja, L. N. and Gonzalez-Crussi, F.: The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin. Immunology, 70: 309-314 (1990).
51. Leist, M., Gantner, F., Naumann, H., Bluethmann, H., Vogt, K., Brigelius-Flohe, R., Nicotera, P., Volk, H. D. and Wendel, A.: Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology, 112: 923-934 (1997).
52. Sakaguchi, S., Furusawa, S., Yokota, K., Sasaki, K., Takayanagi, M. and Takayanagi, Y.: The enhancing effect of tumour necrosis factor-α on oxidative stress in endotoxemia. Pharmacol. Toxicol., 79: 259-265 (1996).
53. Sakaguchi, S., Furusawa, S., Yokota, K., Takayanagi, M. and Takayanagi, Y.: Modification of tumor necrosis factor-induced acute toxicity D-galactosamine challenge by polymyxin B, an antiendotoxin. Int. J. Immunopharmacol., 22: 935-942 (2000).
54. Sakaguchi, S. and Furusawa, S.: Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol. Med. Microbiol., 47: 167-177 (2006).
55. Ronis, M. J. J., Butura, A., Sampey, B. P., Prior, R. L., Korourian, S., Albano, E., Ingelman-Sundberg, M., Petersen, D. R. and Badger, T. M.: Effects of N-acetyl cysteine on ethanolinduced hepatotoxicity in rats fed via total enteral nutrition. Free Radic. Biol. Med., 39: 619-630 (2005).
56. Vidali, M., Hietala, J., Occhino, G., Ivaldi, A., Sutti, S., Niemelä, O. and Albano, E.: Immune responses against oxidative stressderived antigens are associated with increased circulating tumor necrosis factor-α in heavy drinkers. Free Radic. Biol. Med., 45: 306-311 (2008).
57. Hill, D. B., Barve, S., Joshi-Barve, S. and McClain, C. J.: Increased monocyte nuclear factor-kappa B activation and tumor necrosis factor production in alcoholic hepatitis. J. Lab. Clin. Med., 135: 387-395 (2000).
58. Pena, L. R., Hill, D. B. and McClain, C. J.: Treatment with glutathione precursor decreases cytokine activity. JPEN J. Parenter. Enteral Nutr., 23: 1-6 (1999).
59. Yamashina, S., Takei, Y., Ikejima, K., Enomoto, N., Kitamura, T. and Sato, N.: Ethanol-induced sensitization to endotoxin in Kupffer cells is dependent upon oxidative stress. Alcohol. Clin. Exp. Res., 29(12 Suppl.): 246S-250S (2005).
60. Lu, Y. and Cederbaum, A. I.: CYP2E1 and oxidative liver injury by alcohol. Free Radic. Biol. Med., 44: 723-738 (2008).
61. Das, S. K. and Vasudevan, D. M.: Alcohol-induced oxidative stress. Life Sci., 81: 177-187 (2007).
62. Salmela, K. S., Kessova, I. G., Tsyrlov, I. B. and Lieber, C. S.: Respective roles of human cytochrome P-4502E1, 1A2, and 3 in the hepatic microsomal ethanol oxidizing system. Alcohol. Clin. Exp. Res., 22: 2125-2132 (1998).
63. Reinke, L. A.: Spin trapping evidence for alcohol-associated oxidative stress. Free Radic. Biol. Med., 32: 953-957 (2002).
64. Bailey, S. M., Pietsch, E. C. and Cunningham, C. C.: Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III. Free Radic. Biol. Med., 27: 891-900 (1999).
65. Femandez-Checa, J. C., Kaplowitz, N., Garcia-Ruiz, C., Colell, A., Miranda, M., Mari, M., Ardite, E. and Morales, A.: GSH transport in mitochondria: defense against TNF-α induced oxidative stress and alcohol-induced defect. Am. J. Physiol., 273: G7-G17 (1997).
66. Albano, E.: Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc., 65: 278-290 (2006).
67. Mansouri, A., Demeilliers, C., Amsellem, S., Pessayre, D. and Fromenty, B.: Acute ethanol administration oxidatively damages and depletes mitochondrial DNA in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J. Pharmacol. Exp. Ther., 298: 737-743 (2001).
68. Zima, T. and Kalousova, M.: Oxidative stress and signal transduction pathways in alcoholic liver disease. Alcohol. Clin. Exp. Res., 29: 110S-115S (2005).
69. Bradford, B. U., Kono, H., Isayama, F., Kosyk, O., Wheeler, M. D., Akiyama, T. E., Bleye, L., Krausz, K. W., Gonzalez, F. J., Koop, D. R. and Rusyn, I.: Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology, 41: 336-344 (2005).
70. Kono, H., Bradford, B. U., Yin, M., Sulik, K. K., Koop, D. R., Peters, J. M., Gonzalez, F. J., McDonald, T., Dikalova, A., Kadiska, M. B., Mason, R. P. and Thurman, R. G.: CYP2E1 is not involved in early alcohol-induced liver injury. Am. J. Physiol., 277: G1259-G1267 (1999).
71. Vuppalanchi, R. and Chalasani, N.: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology, 49: 306-317 (2009).
72. Bugianesi, E., McCullough, A. J. and Marchesini, G.: Insulin metabolic pathway to chronic liver disease. Hepatology, 42: 987-1000 (2005).
73. Tsochatzis, E. A., Manolakopoulos, S., Papatheodoridis, G. V. and Archimandritis, A. J.: Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implication. Scand. J. Gastroenterol., 44: 6-14 (2009).
74. Parkin, D. M.: Global cancer statistics in the year 2000. Lancet Oncol., 2: 533-543 (2001).
75. Day, C. P. and James, O. F. W.: Steatohepatitis: a tale of two úhitsû. Gastroenterology, 114: 842-845 (1998).
76. Portincasa, P., Grattagliano, I., Palmieri, V. O. and Palasciano, G.: Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin. Biochem., 38: 203-217 (2005).
77. Diehl, A. M.: Lessons from animal models of NASH. Hepatol. Res., 33: 138-144 (2005).
78. Gentile, C. L. and Pagliassotti, M. J.: The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J. Nutr. Biochem., 19: 567-576 (2008).
79. Orellana, M., Rodrigo, R., Varela, N., Araya, J., Poniachik, J., Csendes, A., Smok, G. and Videla, L. A.: Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients. Hepatol. Res., 34: 57-63 (2006).
80. Pessayre, D. and Fromenty, B.: NASH: a mitochondrial disease. J. Hepatol., 42: 928-940 (2005).
81. Liu, H., Jones, B. E., Bradham, C. and Czaja, M. J.: Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Junmediated cell death from TNF-α. Am. J. Physiol. Gastrointest. Liver Physiol., 282: G257-G266 (2002).
82. Kawaratani, H., Tsujimoto, T., Kitazawa, T., Kitada, M., Yoshiji, H., Uemura, M. and Fukui, H.: Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet. World J. Gastroenterol., 14: 6655-6661 (2008).